{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:23:43Z","timestamp":1793701423750,"version":"4.5.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41591-021-01470-y","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T16:03:30Z","timestamp":1631549010000},"page":"1636-1645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0021-3324","authenticated-orcid":false,"given":"Martina","family":"Oneko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0540-9940","authenticated-orcid":false,"given":"Laura C.","family":"Steinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Yego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-1850","authenticated-orcid":false,"given":"Ryan E.","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip A.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"KC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas","family":"Akach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-7322","authenticated-orcid":false,"given":"Julie R.","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Nzuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Dungani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kim Lee Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9771-5525","authenticated-orcid":false,"given":"Paul Ndaya","family":"Oloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kephas","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K.","family":"Bii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1142-4813","authenticated-orcid":false,"given":"Peter F.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-8186","authenticated-orcid":false,"given":"Aaron M.","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Jongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Chebore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Daubenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxmillian","family":"Mpina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Styers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail E.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginnie","family":"Abarbanell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2946-5456","authenticated-orcid":false,"given":"Thomas L.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0700-9505","authenticated-orcid":false,"given":"Stephen L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3133-0849","authenticated-orcid":false,"given":"Robert A.","family":"Seder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"1470_CR1","unstructured":"World Malaria Report 2020: 20 Years of Global Progress and Challenges (WHO, 2020)."},{"key":"1470_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt, S. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526, 207\u2013211 (2015).","journal-title":"Nature"},{"key":"1470_CR3","doi-asserted-by":"publisher","first-page":"e1001685","DOI":"10.1371\/journal.pmed.1001685","volume":"11","author":"ST Agnandji","year":"2014","unstructured":"Agnandji, S. T. et al. Efficacy and safety of the RTS,S\/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 11, e1001685 (2014).","journal-title":"PLoS Med."},{"key":"1470_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","unstructured":"RTS,S Clinical Trials Partnership Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31\u201345 (2015).","journal-title":"Lancet"},{"key":"1470_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","volume":"15","author":"MT White","year":"2015","unstructured":"White, M. T. et al. Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect. Dis. 15, 1450\u20131458 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"1470_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.1241800","volume":"341","author":"RA Seder","year":"2013","unstructured":"Seder, R. A. et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359\u20131365 (2013).","journal-title":"Science"},{"key":"1470_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.4110","volume":"22","author":"AS Ishizuka","year":"2016","unstructured":"Ishizuka, A. S. et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat. Med. 22, 614\u2013623 (2016).","journal-title":"Nat. Med."},{"key":"1470_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.1211548","volume":"334","author":"JE Epstein","year":"2011","unstructured":"Epstein, J. E. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334, 475\u2013480 (2011).","journal-title":"Science"},{"key":"1470_CR9","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1073\/pnas.1615324114","volume":"114","author":"KE Lyke","year":"2017","unstructured":"Lyke, K. E. et al. Attenuated PfSPZ vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc. Natl Acad. Sci. USA 114, 2711\u20132716 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1470_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature21060","volume":"542","author":"B Mordm\u00fcller","year":"2017","unstructured":"Mordm\u00fcller, B. et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 542, 445\u2013449 (2017).","journal-title":"Nature"},{"key":"1470_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1126\/science.1704150","volume":"251","author":"Y Charoenvit","year":"1991","unstructured":"Charoenvit, Y. et al. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science 251, 668\u2013671 (1991).","journal-title":"Science"},{"key":"1470_CR12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4049\/jimmunol.146.3.1020","volume":"146","author":"Y Charoenvit","year":"1991","unstructured":"Charoenvit, Y. et al. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J. Immunol. 146, 1020\u20131025 (1991).","journal-title":"J. Immunol."},{"key":"1470_CR13","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1084\/jem.151.6.1504","volume":"151","author":"P Potocnjak","year":"1980","unstructured":"Potocnjak, P., Yoshida, N., Nussenzweig, R. S. & Nussenzweig, V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J. Exp. Med. 151, 1504\u20131513 (1980).","journal-title":"J. Exp. Med."},{"key":"1470_CR14","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.139.6.2020","volume":"139","author":"L Schofield","year":"1987","unstructured":"Schofield, L., Ferreira, A., Altszuler, R., Nussenzweig, V. & Nussenzweig, R. S. Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J. Immunol. 139, 2020\u20132025 (1987).","journal-title":"J. Immunol."},{"key":"1470_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1073\/pnas.85.2.573","volume":"85","author":"WR Weiss","year":"1988","unstructured":"Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H. & Good, M. F. CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl Acad. Sci. USA 85, 573\u2013576 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1470_CR16","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.4049\/jimmunol.1700314","volume":"199","author":"I Zaidi","year":"2017","unstructured":"Zaidi, I. et al. \u03b3\u03b4 T cells are required for the induction of sterile immunity during irradiated sporozoite vaccinations. J. Immunol. 199, 3781\u20133788 (2017).","journal-title":"J. Immunol."},{"key":"1470_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","volume":"17","author":"MS Sissoko","year":"2017","unstructured":"Sissoko, M. S. et al. Safety and efficacy of PfSPZ vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. Lancet Infect. Dis. 17, 498\u2013509 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"1470_CR18","doi-asserted-by":"publisher","first-page":"e89154","DOI":"10.1172\/jci.insight.89154","volume":"2","author":"JE Epstein","year":"2017","unstructured":"Epstein, J. E. et al. Protection against Plasmodium falciparum malaria by PfSPZ vaccine. JCI Insight 2, e89154 (2017).","journal-title":"JCI Insight"},{"key":"1470_CR19","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4269\/ajtmh.18-0835","volume":"100","author":"SA Jongo","year":"2019","unstructured":"Jongo, S. A. et al. Safety and differential antibody and T-cell responses to Plasmodium falciparum sporozoite vaccine by age in Tanzanian adults, adolescents, children, and infants. Am. J. Trop. Med. Hyg. 100, 1433\u20131444 (2019).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1470_CR20","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.4049\/jimmunol.1202438","volume":"190","author":"J Illingworth","year":"2013","unstructured":"Illingworth, J. et al. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J. Immunol. 190, 1038\u20131047 (2013).","journal-title":"J. Immunol."},{"key":"1470_CR21","doi-asserted-by":"publisher","first-page":"e1002389","DOI":"10.1371\/journal.ppat.1002389","volume":"7","author":"AC Teirlinck","year":"2011","unstructured":"Teirlinck, A. C. et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 7, e1002389 (2011).","journal-title":"PLoS Pathog."},{"key":"1470_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2702-5","volume":"18","author":"H Diallo","year":"2019","unstructured":"Diallo, H. et al. Longitudinal analysis of gamma delta T cell subsets during malaria infections in Malian adults. Malar. J. 18, 69 (2019).","journal-title":"Malar. J."},{"key":"1470_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10624-3","volume":"7","author":"P Jagannathan","year":"2017","unstructured":"Jagannathan, P. et al. V\u03b42+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure. Sci. Rep. 7, 11487 (2017).","journal-title":"Sci. Rep."},{"key":"1470_CR24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.4049\/jimmunol.172.3.1637","volume":"172","author":"SC De Rosa","year":"2004","unstructured":"De Rosa, S. C. et al. Ontogeny of \u03b3\u03b4 T cells in humans. J. Immunol. 172, 1637\u20131645 (2004).","journal-title":"J. Immunol."},{"key":"1470_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41591-018-0315-0","volume":"25","author":"NK Kisalu","year":"2019","unstructured":"Kisalu, N. K. et al. Author correction: a human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite. Nat. Med. 25, 188\u2013189 (2019).","journal-title":"Nat. Med."},{"key":"1470_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4269\/ajtmh.17-1014","volume":"99","author":"SA Jongo","year":"2018","unstructured":"Jongo, S. A. et al. Safety, immunogenicity, and protective efficacy against controlled human malaria infection of Plasmodium falciparum sporozoites vaccine in Tanzanian adults. Am. J. Trop. Med. Hyg. 99, 338\u2013349 (2018).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1470_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1600-065X.2006.00479.x","volume":"215","author":"CT Morita","year":"2007","unstructured":"Morita, C. T., Jin, C., Sarikonda, G. & Wang, H. Nonpeptide antigens, presentation mechanisms, and immunological memory of human V\u03b32V\u03b42 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 215, 59\u201376 (2007).","journal-title":"Immunol. Rev."},{"key":"1470_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout, P. & Hayday, A. Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology. Nat. Rev. Immunol. 13, 88\u2013100 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1470_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nri2781","volume":"10","author":"M Bonneville","year":"2010","unstructured":"Bonneville, M., O\u2019Brien, R. L. & Born, W. K. \u03b3\u03b4 T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10, 467\u2013478 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"1470_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(72)90569-7","volume":"1","author":"BM Greenwood","year":"1972","unstructured":"Greenwood, B. M., Bradley-Moore, A. M., Bryceson, A. D. & Palit, A. Immunosuppression in children with malaria. Lancet 1, 169\u2013172 (1972).","journal-title":"Lancet"},{"key":"1470_CR31","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/infdis\/153.4.763","volume":"153","author":"M Ho","year":"1986","unstructured":"Ho, M. et al. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J. Infect. Dis. 153, 763\u2013771 (1986).","journal-title":"J. Infect. Dis."},{"key":"1470_CR32","first-page":"253","volume":"33","author":"JS McBride","year":"1977","unstructured":"McBride, J. S. & Micklem, H. S. Immunosuppression in murine malaria. II. The primary response to bovine serum albumin. Immunology 33, 253\u2013259 (1977).","journal-title":"Immunology"},{"key":"1470_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/312449a0","volume":"312","author":"HC Whittle","year":"1984","unstructured":"Whittle, H. C. et al. T-cell control of Epstein\u2013Barr virus-infected B cells is lost during P. falciparum malaria. Nature 312, 449\u2013450 (1984).","journal-title":"Nature"},{"key":"1470_CR34","unstructured":"Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events. Version 2.0. https:\/\/rsc.niaid.nih.gov\/clinical-research-sites\/daids-adverse-event-grading-tables (2014)."},{"key":"1470_CR35","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/cid\/ciz925","volume":"71","author":"LC Steinhardt","year":"2020","unstructured":"Steinhardt, L. C. et al. Safety, tolerability, and immunogenicity of PfSPZ vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya. Clin. Infect. Dis. 71, 1063\u20131071 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"1470_CR36","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases. Division of Microbiology and Infectious Diseases (DMID) Pediatric Toxicity Tables November 2007 Draft https:\/\/www.niaid.nih.gov\/sites\/default\/files\/dmidpedtox.pdf (2007)."},{"key":"1470_CR37","unstructured":"World Health Organization. Microscopy for the Detection, Identification and Quantification of Malaria Parasites on Stained Thick and Thin Films in Research Settings (WHO, 2015)."},{"key":"1470_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-223","volume":"10","author":"C Swysen","year":"2011","unstructured":"Swysen, C. et al. Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S\/AS01 candidate malaria vaccine. Malar. J. 10, 223 (2011).","journal-title":"Malar. J."},{"key":"1470_CR39","unstructured":"Informal Consultation on Quality Control of Malaria Microscopy (WHO, 2006)."},{"key":"1470_CR40","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1128\/JCM.00565-14","volume":"52","author":"SM Taylor","year":"2014","unstructured":"Taylor, S. M. et al. A quality control program within a clinical trial Consortium for PCR protocols to detect Plasmodium species. J. Clin. Microbiol. 52, 2144\u20132149 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"1470_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0166-6851(01)00379-6","volume":"118","author":"CC Hermsen","year":"2001","unstructured":"Hermsen, C. C. et al. Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol. Biochem. Parasitol. 118, 247\u2013251 (2001).","journal-title":"Mol. Biochem. Parasitol."},{"key":"1470_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jim.2016.08.009","volume":"439","author":"M Beddall","year":"2016","unstructured":"Beddall, M., Chattopadhyay, P. K., Kao, S.-F., Foulds, K. & Roederer, M. A simple tube adapter to expedite and automate thawing of viably frozen cells. J. Immunol. Methods 439, 74\u201378 (2016).","journal-title":"J. Immunol. Methods"},{"key":"1470_CR43","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/cyto.a.24189","volume":"97","author":"PA Swanson 2nd","year":"2020","unstructured":"Swanson, P. A.2nd & Seder, R. A. OMIP-067: 28-color flow cytometry panel to evaluate human T-cell phenotype and function. Cytometry A 97, 1032\u20131036 (2020).","journal-title":"Cytometry A"},{"key":"1470_CR44","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1093\/bioinformatics\/btw191","volume":"32","author":"G Monaco","year":"2016","unstructured":"Monaco, G. et al. flowAI: automatic and interactive anomaly discerning tools for flow cytometry data. Bioinformatics 32, 2473\u20132480 (2016).","journal-title":"Bioinformatics"},{"key":"1470_CR45","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou, G. A modified Poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 159, 702\u2013706 (2004).","journal-title":"Am. J. Epidemiol."},{"key":"1470_CR46","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1214\/aos\/1176345976","volume":"10","author":"PK Andersen","year":"1982","unstructured":"Andersen, P. K. & Gill, R. D. Cox\u2019s regression model for counting processes: a large sample study. Ann. Stat. 10, 1100\u20131120 (1982).","journal-title":"Ann. Stat."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01470-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T02:48:07Z","timestamp":1673232487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-021-01470-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1038\/s41591-021-01470-y","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"16 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.L.R., N.K.C., P.F.B., E.R.J., B.K.L.S. and S.L.H. are employees of Sanaria, which manufactures the vaccine tested in this study. S.L.H. and B.K.L.S. are named inventors on patents related to the PfSPZ Vaccine. All other authors report no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}